Detalles de la búsqueda
1.
Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials.
Lancet
; 399(10326): 729-740, 2022 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085502
2.
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials.
Lancet
; 399(10326): 741-755, 2022 02 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35085503
3.
Outcomes with As-Needed Ranibizumab after Initial Monthly Therapy: Long-Term Outcomes of the Phase III RIDE and RISE Trials.
Ophthalmology
; 122(12): 2504-13.e1, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26452713
4.
EMerging BiomARKers in Inflammatory Bowel Disease (EMBARK) study identifies fecal calprotectin, serum MMP9, and serum IL-22 as a novel combination of biomarkers for Crohn's disease activity: role of cross-sectional imaging.
Am J Gastroenterol
; 108(12): 1891-900, 2013 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-24126633
5.
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale.
Ophthalmol Sci
; 3(3): 100302, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37810589
6.
YOSEMITE and RHINE: Phase 3 Randomized Clinical Trials of Faricimab for Diabetic Macular Edema: Study Design and Rationale.
Ophthalmol Sci
; 2(1): 100111, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36246184
7.
TENAYA and LUCERNE: Rationale and Design for the Phase 3 Clinical Trials of Faricimab for Neovascular Age-Related Macular Degeneration.
Ophthalmol Sci
; 1(4): 100076, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36246941
8.
Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration: The STAIRWAY Phase 2 Randomized Clinical Trial.
JAMA Ophthalmol
; 138(9): 964-972, 2020 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729897
9.
Ranibizumab in Diabetic Retinopathy with or without Diabetic Macular Edema.
Ophthalmol Retina
; 4(10): 1034-1036, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32512056
Resultados
1 -
9
de 9
1
Próxima >
>>